Trump Drops a Flurry of Nominees to Head FDA, OMB, CDC, and HUD
We Might Have a Problem With Trump's Labor Secretary Nominee
Trump Makes His Pick for Treasury Secretary
The Press Delivers a Fake News Trump Health Crisis, and the Bad Week...
Wisdom From the Founders: Madison and 'Gradual and Silent Encroachments'
CFPB Director Exemplifies the Worst of Washington Hypocrisy
Trump Victory: From Neocons to Americons
It’s Time to Make Healthcare Great Again
Deportation Is Necessary to Undo Harm Done at the Border
Do You Know Where the Migrant Children Are? Why States Can't Wait for...
Biden’s Union-Based Concerns Undercut U.S. Security and Jeopardize Steel Production
Joy Reid Spews Hate Toward Trump Supporters Once Again
America's National Debt Just Hit a New Record
The View Forced to Read Three Legal Notes Within Minutes of One Another...
Watch This ABC Reporter Goes on Massive Tangent Blaming Trump for Laken Riley's...
Tipsheet

Tulsi Gabbard: The Biden Administration Is Promoting Child Abuse

(AP Photo/John Minchillo)

Former Democratic Congresswoman Tulsi Gabbard took to her social media pages over the weekend to highlight a new Food and Drug Administration warning about puberty blockers. 

Advertisement

According to the FDA, these drugs can cause blindness and other permanent injuries when taken by children. 

The Food and Drug Administration (FDA) has added a warning about the risk of pseudotumor cerebri (idiopathic intracranial hypertension) to the labeling for gonadotropin-releasing hormone (GnRH) agonists that are approved for the treatment of central precocious puberty in pediatric patients. These products include Lupron Depot-Ped (leuprolide acetate), Fensolvi (leuprolide acetate), Synarel (nafarelin), Supprelin LA (histrelin) and Triptodur (triptorelin).

The new warning includes recommendations to monitor patients taking GnRH agonists for signs and symptoms of pseudotumor cerebri, including headache, papilledema, blurred or loss of vision, diplopia, pain behind the eye or pain with eye movement, tinnitus, dizziness and nausea.

The FDA assessed the potential risk of pseudotumor cerebri with use of GnRH agonists in pediatric patients by reviewing post-marketing safety data submitted by the GnRH agonist manufacturers, searching the FDA Adverse Event Reporting System and conducting a literature search.

Advertisement

For months the Biden administration has been in a full court press to "affirm" gender "care" for children. That so-called "care" includes using taxpayer dollars to pay for puberty blockers and medical castration for young kids through Medicaid. 

"Providing resources on the importance of gender affirming care for children and adolescents. The Office of the Assistant Secretary for Health has developed a resource to inform parents and guardians, educators, and other persons supporting children and adolescents with information on what is gender-affirming care and why it is important to transgender, nonbinary, and other gender expansive young people’s well-being," the White House released in a March "fact sheet." 

Biden's U.S. Assistant Secretary of Health Dr. Levine has repeatedly stressed the "necessity" for children to be encouraged to use these kinds of drugs. 

Advertisement

During Levine's confirmation hearing, Republican Senator Dr. Rand Paul asked about Levine's support for these dangerous drugs. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement